VI
Viyash Scientific Limited
VIYASH.NS · NSE
₹256.95 -1.34% (-₹3.50)
1M -3.27%
Market Cap ₹113.0B
P/E Ratio 66.05x
Div. Yield -
ROE 12.73%
Bulios Fair Price
₹144.69
43.7% downside
Trenutna cena
₹256.95
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica VIYASH.NS trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
18 /100
Expensive P/E 66.05x
EV/EBITDA 19.72x
P/FCF 392.51x
Growth
21 /100
Declining EPS growth 19.51%
Rev. growth 3.23%
Book val. growth 0.59%
Profitability
41 /100
Moderate Gross margin 33.88%
Net margin 5.44%
FCF margin 0.91%
Quality
47 /100
Average ROIC 6.68%
ROE 12.73%
Asset turnover 0.68x
Debt
93 /100
Low Debt/Equity 0.17x
Current ratio 2.38x
Net debt/EBITDA 0.38x
Stability
55 /100
Moderate Beta 0.97x
Rev. volatility 8.97%
Profitable years 1
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o VIYASH.NS
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Haribabu Bodepudi
Employees
1,244
Headquarters
Hyderabad
Prihajajoči dogodki
14 NOV.
Earnings
Upcoming earnings report